FATE THERAPEUTICS INC — Director's Dealing 2016

Jan 20, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2016-01-18

Reporting Person: Wolchko J Scott (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-18	Common Stock	M	3798	$1.37	Acquired	135777	Direct
2016-01-18	Common Stock	M	3702	$1.63	Acquired	139479	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-18	Stock Option (right to buy)	$1.37	M	3798	Disposed	2022-07-23	Common Stock (3798)	Direct
2016-01-18	Stock Option (right to buy)	$1.63	M	3702	Disposed	2022-02-08	Common Stock (3702)	Direct

Footnotes

F1: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on August 3, 2012 such that this option is fully exercisable on July 3, 2016. This option is subject to accelerated vesting upon a change of control of the Issuer and in the event of termination of employment under certain circumstances following a change of control of the Issuer.

F2: Not applicable.

F3: The shares subject to this option became fully vested and exercisable on May 30, 2015.